Schimmel Paul
aTyr Pharma, Inc. · Director
Schimmel Paul is listed in public filings as director. This Schimmel Paul insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include aTyr Pharma, Inc. (ATYR). Investors use Schimmel Paul's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $387k779.1k shares | BuyMay 27, 2026 | $49.6K100k shares | $0.4963 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $48k50k shares | Grant / ExerciseMay 11, 2026 | $47.5K50k shares | $0.95 | -- | |
| $1.3M1.4M shares | BuyOct 9, 2025 | $299.4K318k shares | $0.9414 | -- | |
| $983k1.1M shares | BuyOct 8, 2025 | $612.4K682k shares | $0.898 | -- | |
| $167k50k shares | Grant / ExerciseMay 1, 2025 | $167.0K50k shares | $3.34 | -- | |
| $798k413k shares | BuyJul 24, 2024 | $101.0K52.3k shares | $1.93 | -- | |
| $655k360.7k shares | BuyJul 23, 2024 | $12.1K6.6k shares | $1.82 | -- | |
| $617k354.1k shares | BuyJul 22, 2024 | $71.5K41.1k shares | $1.74 | -- |